The 146th Annual Meeting of the Pharmaceutical Society of Japan (Osaka)

Organizer: Takehisa Hanawa (Tokyo Univ. of Science), Kenji Momo (Sch. Pharm., Showa Med. Univ.), Yasuharu Kashiwagura (Sch. Pharm. Sci., Teikyo Univ.), Tsutomu Harada (Cli. Res. Inst.Cli. Pharmacol. Ther., Showa Med. Univ.), Seiji Mochizuki (Teijin Regenet Co., Ltd.)

Co-sponsored by:
The Pharmaceutical Society of Japan,
The Academy of Pharmaceutical Science and Technology, Japan

Pharmacists engage in "preparing suspensions, disinfectants, and other formulations by crushing tablets, pulverizing solid dosage forms by opening capsules, and suspending them" as an extension of dispensing duties to satisfy pharmaceutical needs in healthcare settings. Such preparations have developed as "in-hospital formulations"—not commercially available but created as needed for therapeutic purposes.
We determined that establishing the shelf life and storage conditions for these "in-hospital preparations" requires a basis grounded in the examination of their physicochemical properties. Furthermore, we concluded that establishing such quality control and clinical rationale is necessary not only for preparations used within medical institutions but also for those prepared and used in community pharmacies involved in home healthcare. Consequently, we expanded the term "in-hospital preparations" to encompass "clinical preparations."
Regarding the preparation of in-hospital preparations, the "Guidelines for the Preparation and Use of In-Hospital Preparations" have been issued. However, compliance with these guidelines requires more specialized knowledge and skills. To ensure such expertise, various specialist pharmacist systems, such as oncology pharmacists and pharmacotherapy specialists, have been established, with many specialist pharmacists demonstrating their expertise in clinical settings.
Therefore, at this symposium, held jointly with the Japanese Society of Pharmaceutical Sciences, we propose the establishment of a "Clinical Compounding Specialist Pharmacist" designation. This would enable pharmacists involved in clinical compounding to further demonstrate their capabilities as Pharmacist-Scientists. Through discussions with speakers and participants, we aim to explore the feasibility of establishing this designation.